Dr. Anushareddy Muddasani, MD

Dr. Muddasani practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Dr. Muddasani's NPI, 1760919872, was assigned on May 19, 2017. Dr. Muddasani holds Arkansas license E-13414.

Dr. Muddasani's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Dr. Muddasani's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Dr. Muddasani to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muddasani practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Muddasani's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Muddasani is licensed in Arkansas.

CMS data shows 372 Medicare services from Dr. Muddasani across 4 procedure codes in 2024, for 82 Medicare patients. Medicare paid $28,838 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 82 Medicare patients who saw Dr. Muddasani in 2024. The largest group is under 65, with 31 patients. 75% of them have high blood pressure, and 62% have high cholesterol. 34% are also on Medicaid. Their average risk score is 3.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Muddasani's median patient age at 69, with 55% women.

In 2024, Dr. Muddasani wrote 332 Medicare Part D claims for 141 patients. 92% of them were for generic drugs. CMS names the drug for 103 of them, across 7 drugs with 11 or more claims each, at $1,111 in total drug cost. In 2023, CMS named 6,702 claims across 114 drugs.

Dr. Muddasani accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Muddasani in 2019. Dr. Muddasani's most frequent co-author is Aijaz H. Turk.

CMS Open Payments shows 42 general payments to Dr. Muddasani from 20 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 100% of the total. Biohaven Pharmaceuticals, Inc. paid the most, $124.